Very few patients ever receive an eye cancer diagnosis. But when they do, it’s typically for uveal melanoma, and they often face an uphill battle. This cancer frequently resists treatment, and it can metastasize (spread) through the body.
UW Medicine has joined a select group of research teams nationwide to find a solution. They are testing a new drug and delivery method that could shrink uveal melanoma tumors that have spread to other organs.
Oncologists from the Fred Hutchinson Cancer Center and interventional radiologists from UW Medicine are introducing this new therapeutic approach to local patients in a clinical trial.
“Uveal melanoma is a complicated disease, so we’re taking a multi-pronged, multi-specialty approach to combat it,” says Wayne Monsky, MD, PhD, a vascular and interventional radiologist involved with the clinical trial.
